Patents by Inventor Stéphanie Reader

Stéphanie Reader has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of imatinib to treat liver disorders and viral infections
    Patent number: 8293745
    Abstract: The present invention relates to the use of imatinib for treating viral liver diseases and in particular for viral hepatitis. The invention provides the use of imatinib for inhibiting replication, transmission or both of hepatitis viruses. The invention further relates to the use of imatinib for inhibiting replication, transmission or both of other viruses including herpes virus, poxvirus, influenza virus, para influenza virus, respiratory syncytial virus, rhinovirus, yellow fever virus, west nile virus, and encephalitis virus.
    Type: Grant
    Filed: September 14, 2005
    Date of Patent: October 23, 2012
    Assignee: Bioniche Life Sciences Inc.
    Inventors: Phillippe Riviere, Marc Riviere, Stéphanie Reader
  • Oligonucleotide compositions and their use to induce apoptosis
    Patent number: 7199228
    Abstract: The present invention provides novel synthetic oligonucleotide sequences (hereinafter sequence) of 3 to 9 bases in length comprising one or more non-DNA bases wherein the bases are nebularine, hypoxanthine, or uracil, or combinations of nebularine, hypoxanthine and uracil bases. These sequences optionally further comprise one or more guanine bases or one or more thymine bases, or combinations thereof. The present invention also provides methods of using these compositions to induce responses in cells, and to treat diseases and conditions characterized by undesired cellular proliferation such as autoimmune disease, lymphoproliferative disease, inflammation or cancer.
    Type: Grant
    Filed: August 19, 2002
    Date of Patent: April 3, 2007
    Assignee: Bioniche Life Sciences, Inc
    Inventors: Nigel C. Phillips, Mario C. Filion, Zdenek Richard Holan, Stéphanie Reader
  • Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
    Patent number: 7200531
    Abstract: The present invention facilitates in silico evaluation of molecules for biological activity by providing a computer-based method to predict whether oligonucleotides may possess biological activity and the efficacy of the biological activity based on the three-dimensional structure and charge characteristics of the oligonucleotides. Biological activities include, but are not limited to, cellular proliferation, induction of cell cycle arrest and apoptosis.
    Type: Grant
    Filed: August 19, 2002
    Date of Patent: April 3, 2007
    Assignee: Bionicrie Life Sciences, Inc.
    Inventors: Nigel C. Phillips, Mario C. Filion, Zdenek Richard Holan, Stéphanie Reader